Doxorubicin Inactivates Myocardial Cytochrome c Oxidase in Rats: Cardioprotection by Mito-Q

被引:147
作者
Chandran, Karunakaran [1 ,2 ]
Aggarwal, Deepika [3 ]
Migrino, Raymond Q. [4 ]
Joseph, Joy [1 ,2 ]
McAllister, Donna [1 ,2 ]
Konorev, Eugene A. [5 ]
Antholine, William E. [1 ,2 ]
Zielonka, Jacek [1 ,2 ]
Srinivasan, Satish [6 ]
Avadhani, Narayan G. [6 ]
Kalyanaraman, B. [1 ,2 ]
机构
[1] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Free Rad Res Ctr, Milwaukee, WI 53226 USA
[3] Dr Reddys Labs, Hyderabad, Andhra Pradesh, India
[4] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
[5] Univ Hawaii, Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA
[6] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA
关键词
ELECTRON-PARAMAGNETIC-RESONANCE; BREAST-CANCER PATIENTS; REACTIVE OXYGEN; NITRIC-OXIDE; ANTHRACYCLINE CARDIOTOXICITY; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; ENDOTHELIAL-CELLS; RESPIRATORY-CHAIN; INDUCED APOPTOSIS;
D O I
10.1016/j.bpj.2008.10.042
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Doxorubicin (DOX) is used for treating various cancers. Its clinical use is, however, limited by its dose-limiting cardiomyopathy. The exact mechanism of DOX-induced cardiomyopathy still remains unknown. The goals were to investigate the molecular mechanism of DOX-induced cardionnyopathy and cardioprotection by mitoquinone (Mito-Q), a triphenylphosphonium-conjugated analog of coenzyme Q, using a rat model. Rats were treated with DOX, Mito-Q, and DOX plus Mito-Q for 12 weeks. The left ventricular function as measured by two-dimensional echocardiography decreased in DOX-treated rats but was preserved during Mito-Q plus DOX treatment. Using low-temperature ex vivo electron paramagnetic resonance (EPR), a time-dependent decrease in heme signal was detected in heart tissues isolated from rats administered with a cumulative dose of DOX. DOX attenuated the EPR signals characteristic of the exchange interaction between cytochrome c oxidase (CcO)-Fe(III) heme a(3) and Cu-B. DOX and Mito-Q together restored these EPR signals and the CcO activity in heart tissues. DOX strongly clownregulated the stable expression of the CcO subunits II and Va and had a slight inhibitory effect on CcO subunit I gene expression. Mito-Q restored CcO subunit II and Va expressions in DOX-treated rats. These results suggest a novel cardioprotection mechanism by Mito-O during DOX-induced cardiomyopathy involving CcO.
引用
收藏
页码:1388 / 1398
页数:11
相关论文
共 57 条
  • [1] Redox reactions of the iron-sulfur cluster in a ribosomal RNA methyltransferase, RumA - Optical and EPR studies
    Agarwalla, S
    Stroud, RM
    Gaffney, BJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (33) : 34123 - 34129
  • [2] Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant
    Asin-Cayuela, J
    Manas, ARB
    James, AM
    Smith, RAJ
    Murphy, MP
    [J]. FEBS LETTERS, 2004, 571 (1-3): : 9 - 16
  • [3] BRISTOW MR, 1978, CANCER TREAT REP, V62, P873
  • [4] The nature of the exchange coupling between high-spin Fe(III) herne o3 and CuB(II) in Escherichia coli quinol oxidase, cytochrome bo3:: MCD and EPR studies
    Cheesman, MR
    Oganesyan, VS
    Watmough, NJ
    Butler, CS
    Thomson, AJ
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (13) : 4157 - 4166
  • [5] Conklin Kenneth A, 2005, Integr Cancer Ther, V4, P110, DOI 10.1177/1534735405276191
  • [6] COOPER CE, 1992, J BIOL CHEM, V267, P280
  • [7] DAVIES KJA, 1986, J BIOL CHEM, V261, P3060
  • [8] Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: Role of mitochondrial superoxide
    Dhanasekaran, A
    Kotamraju, S
    Karunakaran, C
    Kalivendi, SV
    Thomas, S
    Joseph, J
    Kalyanaraman, B
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2005, 39 (05) : 567 - 583
  • [9] Dorr RT, 1996, SEMIN ONCOL, V23, P23
  • [10] Chemotherapy and cardiotoxicity in older breast cancer patients: A population-based study
    Doyle, JJ
    Neugut, AI
    Jacobson, JS
    Grann, VR
    Hershman, DL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8597 - 8605